Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Vectura Group plc (VEC) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Vectura Group develops therapies principally for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The company has six products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development. VEC has development collaborations and license agreements with several pharmaceutical companies, including Novartis, Sandoz, Baxter and GlaxoSmithKline. For more information, visit the company’s Web site: http://www.vectura.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *